NCT04704778

Brief Summary

The objective is to compare the neuromuscular electrical activity and muscle fatigue of the masseter muscles in three groups of patients with different treatments for TMD (GA = Transcutaneous electrostimulation and splint, GB = percutaneous electrostimulation and splint, and GC = Occlusal splint) by means of 6 electromyographic recordings scheduled weekly. The study population will be patients with TMD who will enter the Physiology Laboratory of the Division of Postgraduate Studies and Research (DEPeI) UNAM, admitted during the period from March to December 2021 The selection of the sample will be carried out by convenience sampling which will be carried out based on the clinical evaluation (considering the inclusion and exclusion criteria). The recruitment period will take place during the period from March to December 2021. The selected sample will be divided into three groups (GA = transcutaneous electrostimulation and splint, GB = percutaneous electrostimulation and splint, GC = splint); the allocation by group will be made by means of a randomization in balanced blocks. The total sample size calculated for this study was 84 patients, 28 for each group. The diagnostic process of Temporomandibular Dysfunction (TMD) will be carried out by the Principal Investigator using the Diagnostic Criteria and Investigation of Temporomandibular Disorders (CDI / TMD).

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2022

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 15, 2020

Completed
28 days until next milestone

First Posted

Study publicly available on registry

January 12, 2021

Completed
12 months until next milestone

Study Start

First participant enrolled

January 1, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

September 13, 2021

Status Verified

September 1, 2021

Enrollment Period

7 months

First QC Date

December 15, 2020

Last Update Submit

September 2, 2021

Conditions

Keywords

ElectromyographicElectrostimulation therapy

Outcome Measures

Primary Outcomes (2)

  • Neuromuscular electrical activity

    Mathematical Root Mean Square (RMS) value Micro Voltios (µV.) determined by the EMG UNAM-CINVESTAV program, which represents the average of the squared values of the electromyographic activity of the right and left masseter muscles.

    Two months (every week with a total of six continuous records)

  • Muscular fatigue

    Micro Voltios (µV.) Mathematical Hurst Index value determined by the EMG UNAM-CINVESTAV program, which represents the average of the squared values of the electromyographic activity of the right and left masseter muscles

    Two months (every week with a total of six continuous records)

Secondary Outcomes (5)

  • Temporomandibular dysfunction (DTM)

    Day 1

  • Muscle pain

    Two months (every week with a total of six continuous records)

  • Limitation of mouth opening

    Two months (every week with a total of six continuous records)

  • Presence of joint noises

    Two months (every week with a total of six continuous records)

  • Heart rate

    Two months (every week with a total of six continuous records)

Study Arms (3)

Transcutaneous

ACTIVE COMPARATOR

Transcutaneous electrostimulation and uso of oclusal splint

Combination Product: Transcutaneus electrostimulation therapiesCombination Product: Percutaneus electrostimulation therapiesDiagnostic Test: Oclusal splint

Percutaneous

ACTIVE COMPARATOR

Percutaneous electrostimulation and splint

Combination Product: Transcutaneus electrostimulation therapiesCombination Product: Percutaneus electrostimulation therapiesDiagnostic Test: Oclusal splint

Control

PLACEBO COMPARATOR

Oclusal splint

Diagnostic Test: Oclusal splint

Interventions

Sterile steel acupuncture needles of 0.25x13mm, disposable AcuBEST brand, and portable electro-stimulator equipment KWD- will be used. The superficial area of the skin of the masseter muscle will be cleaned with alcohol. Two needles will be placed in each masseter muscle, the area to be punctured is the origin of the masseter muscle or superficial area of the mandibular condyle anterior to the atrial tragus approximately 1cm away, insertion of the masseter muscle at the angle of the mandible. The two double alligator cables will be connected to the head of the needles. The positive pole will be connected at the origin of the masseter muscle and the negative pole at the insertion. The parameters to be used will be are two frequency bands (210Hz-10140Hz.); amplitude 3050 volts, pulse duration: 40100 msec; and the output intensity: 0.70 (for 100Hz). The treatment time will be 20 minutes.

Also known as: Electroacupuntur
PercutaneousTranscutaneous

Kendall® MediTrace 100 conductive adhesive ECG electrodes (pediatric) 2.4 cm in diameter, and portable KWD-808 electrostimulator equipment will be used. The superficial area of the skin will be cleaned, two electrodes will be placed on each muscle (superficial area of the mandibular condyle and at the angle of the jaw). The current leads will then be connected to the KWD-808 electroacupuncturist to the patient. Current will be transmitted with a square waveform, 210Hz-10140Hz of frequency, 3050 volts of amplitude and 40100 msec pulse time. The treatment time will be 20 minutes.

Also known as: TENS
PercutaneousTranscutaneous
Oclusal splintDIAGNOSTIC_TEST

The occlusal splint is worn 24 hours a day, removed for eating and brushing teeth. It is washed with neutral liquid hand soap. For the preparation, an impression of the maxillary dental arches will be taken with alginate; It is made with acetate .060 and .080. Relining is done with self-curing acrylic on the occlusal surface of the splint

Also known as: Control
ControlPercutaneousTranscutaneous

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients assigned to the DEPeI Physiology Laboratory.
  • Age range 18 to 60 years
  • Without prior treatment of TTM or DTM
  • Permanent dentition
  • With malocclusion
  • With prosthetic or implant treatments
  • Partially toothless arches
  • Bruxists
  • Deviation to mandibular opening or closure
  • Presence of joint noises depending
  • Myofascial or joint pain

You may not qualify if:

  • Degenerative joint disease
  • Periodontal problems
  • Orthodontic treatment
  • Apparent neurological or sensory disabilities
  • Patients with bleeding disorders or with anticoagulant intake
  • Patients with pacemakers, defibrillators, or heart conditions
  • Epilepsy, thrombophlebitis, active or uncontrolled phlebitis
  • Facial wounds or severe acne
  • Apparent Neurological or muscular disorders
  • Allergic to metal
  • Acute inflammatory processes or infections
  • Pregnant
  • Joint surgical history
  • Malignancies
  • Degenerative bone diseases
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Links

MeSH Terms

Conditions

Temporomandibular Joint DisordersFacial Pain

Interventions

Transcutaneous Electric Nerve Stimulation

Condition Hierarchy (Ancestors)

Craniomandibular DisordersMandibular DiseasesJaw DiseasesMusculoskeletal DiseasesJoint DiseasesMuscular DiseasesStomatognathic DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsPhysical Therapy ModalitiesRehabilitationAnalgesiaAnesthesia and Analgesia

Study Officials

  • Julio Morales, Bachelor

    Universidad Nacional Autonoma de Mexico

    STUDY CHAIR

Central Study Contacts

Claudia I Rodriguez, Master

CONTACT

Fernando Ángeles, Doctoral

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Blind observer: A third party (statesman) is used, who does not know the treatment that each person is receiving. patient, to assess the response.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The selected sample will be divided into three groups (GA = transcutaneous electrostimulation and splint, GB = percutaneous electrostimulation and splint, GC = splint); the allocation by group will be made by means of a randomization in balanced blocks. For this process, a series of blocks will be assembled made up of a certain number of cells in which the types of treatment are included. The number of blocks will be determined by the number of participants to be included in the study and the number of cells that it has been decided to include in each block. Each block will contain in each cell one of the treatment alternatives and within each block there must be a balanced number of possible treatments.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Master of Clinical Dental Sciences

Study Record Dates

First Submitted

December 15, 2020

First Posted

January 12, 2021

Study Start

January 1, 2022

Primary Completion

August 1, 2022

Study Completion

December 1, 2022

Last Updated

September 13, 2021

Record last verified: 2021-09